Lee Epstein, MD
Urogynecology and Reconstructive Pelvic Surgery · Jacksonville Beach, FLNPI 1174518401
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,550 of the $5,764 with a category attached, or 78.9%. Astellas Pharma US Inc accounts for 86.2% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $5,085 and has fallen 97.8% since, to $111 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in FL, where the typical reported total is $5,437.
Across 38 payments — averaging $151.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$5K
- Coloplast$335
- Escala Medical Inc.$168
- Caldera Medical, Inc$64
- Axonics, Inc.$45
- Pfizer$34
- plus $149 from 8 others
What the payments were for
- Speaking & faculty fees$4,55079%
- Food & beverage$1,21421%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 19 | $4,969 |
| Coloplast | 4 | $335 |
| Escala Medical Inc. | 1 | $168 |
| Caldera Medical, Inc | 1 | $64 |
| Axonics, Inc. | 2 | $45 |
| Pfizer | 2 | $34 |
| Therapeuticsmd, Inc. | 2 | $31 |
| KARL Storz Endoscopy-america | 1 | $26 |
| 180 Medical, Inc. | 1 | $20 |
| Boston Scientific | 1 | $17 |
| Bard Access Systems, Inc. | 1 | $16 |
| Mission Pharmacal Company | 1 | $14 |
| Medtronic | 1 | $12 |
| AbbVie | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,764 in reported general payments places this provider in the 50th percentile of 81 urogynecology and reconstructive pelvic surgery providers in Florida.
See all urogynecology and reconstructive pelvic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 243 | $178,883 |
| GemtesaVibegron | 143 | $122,142 |
| Mirabegron ErMirabegron | 19 | $12,768 |
| Estradiol | 177 | $12,047 |
| Trospium Chloride ErTrospium Chloride | 22 | $3,782 |
| Solifenacin Succinate | 91 | $2,844 |
| YuvafemEstradiol | 14 | $2,496 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 11 | $1,080 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 39 | $785 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 100 | $718 |
| NitrofurantoinNitrofurantoin Macrocrystal | 16 | $684 |
| Clobetasol Propionate | 20 | $590 |
| Amitriptyline Hcl | 32 | $563 |
| LoperamideLoperamide Hcl | 25 | $523 |
| Trospium Chloride | 12 | $518 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $4,969 | $178,883243 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 81 urogynecology and reconstructive pelvic surgery providers in Florida.
Other urogynecology and reconstructive pelvic surgery in Jacksonville Beach
- Nathan KowOrlando$116K
- Amir ShariatiCoconut Creek$106K
- Charbel SalamonOrlando$100K
- Allison WymanTampa$69K
- Nicole SzellLargo$54K
- Jose Lazaro WeissOviedo$28K
- Paul PettitJacksonville$27K
- Arash RahiCoconut Creek$23K
- Moises VirellesWellington$21K
- Marja SprockRockledge$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.